Wikrom KarnsakulThaschawee ArkachaisriKanit AtisookWanee WisuthsarewongYudhtana SattawatthamrongPrapun AanpreungWest Virginia University School of Medicine MorgantownMahidol UniversityDepartment of Pediatrics2018-08-202018-08-202006-06-19Annals of Hepatology. Vol.5, No.2 (2006), 116-1192-s2.0-33745040344https://repository.li.mahidol.ac.th/handle/20.500.14594/23721Vanishing bile duct syndrome (VBDS) is a rare disorder and requires a liver biopsy for a diagnosis. The condition has not been reported in children with toxic epidermal necrolysis (TEN). The etiology of VBDS in our patient with TEN is most likely from drug hypersensitivity. A high index of suspicion will prompt clinicians to start more specific investigations and treatments. The use of immunosuppressive agents, intravenous immunoglobulin and ursodeoxycholic acid has not been consistently successful in these patients. A new approach with biologic agents such as anti-tumor necrosis factor-α may be a promising therapy and reduce severe adverse outcomes.Mahidol UniversityMedicineArticleSCOPUS